Literature DB >> 21965173

Calcium phosphate-based composite nanoparticles in bioimaging and therapeutic delivery applications.

Amra Tabaković1, Mark Kester, James H Adair.   

Abstract

Bioimaging and therapeutic delivery applications are areas of biomedicine where nanoparticles have had significant impact, but the use of a nanomaterial in these applications can be limited by its physicochemical properties. Calcium phosphate-based composite nanoparticles are nontoxic and biodegradable, and are therefore considered attractive candidates for bioimaging and therapeutic drug delivery applications. Also, the pH-dependent solubility profiles of calcium phosphate materials make this class of nanoparticles especially useful for in vitro and in vivo delivery of dyes, oligonucleotides, and drugs. In this article, we discuss how calcium phosphate-based composite nanoparticles fulfill some of the requirements typically made for nanoparticles in biomedical applications. We also highlight recent studies in bioimaging and therapeutic delivery applications focusing on how these studies have addressed some of the challenges associated with using these nanoparticles in bioimaging and delivery of therapeutics.
Copyright © 2011 John Wiley & Sons, Inc.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21965173     DOI: 10.1002/wnan.163

Source DB:  PubMed          Journal:  Wiley Interdiscip Rev Nanomed Nanobiotechnol        ISSN: 1939-0041


  16 in total

Review 1.  Calcium Phosphate Bioceramics: A Review of Their History, Structure, Properties, Coating Technologies and Biomedical Applications.

Authors:  Noam Eliaz; Noah Metoki
Journal:  Materials (Basel)       Date:  2017-03-24       Impact factor: 3.623

2.  Nanoparticle delivery of pooled siRNA for effective treatment of non-small cell lung cancer.

Authors:  Yang Yang; Yunxia Hu; Yuhua Wang; Jun Li; Feng Liu; Leaf Huang
Journal:  Mol Pharm       Date:  2012-06-22       Impact factor: 4.939

3.  DNA-Templated Strontium-Doped Calcium Phosphate Nanoparticles for Gene Delivery in Bone Cells.

Authors:  Razieh Khalifehzadeh; Hamed Arami
Journal:  ACS Biomater Sci Eng       Date:  2019-05-22

4.  Nanoparticle delivery of HIF1α siRNA combined with photodynamic therapy as a potential treatment strategy for head-and-neck cancer.

Authors:  Wei-Hua Chen; Rumwald Leo G Lecaros; Yu-Cheng Tseng; Leaf Huang; Yih-Chih Hsu
Journal:  Cancer Lett       Date:  2015-01-14       Impact factor: 8.679

Review 5.  Novel strategies for managing pancreatic cancer.

Authors:  Welley S Loc; Jill P Smith; Gail Matters; Mark Kester; James H Adair
Journal:  World J Gastroenterol       Date:  2014-10-28       Impact factor: 5.742

Review 6.  Intelligent design of multifunctional lipid-coated nanoparticle platforms for cancer therapy.

Authors:  Srinivas Ramishetti; Leaf Huang
Journal:  Ther Deliv       Date:  2012-12

7.  PhotoImmunoNanoTherapy reveals an anticancer role for sphingosine kinase 2 and dihydrosphingosine-1-phosphate.

Authors:  Brian M Barth; Sriram S Shanmugavelandy; James M Kaiser; Christopher McGovern; Erhan İ Altınoğlu; Jeremy K Haakenson; Jeremy A Hengst; Evan L Gilius; Sarah A Knupp; Todd E Fox; Jill P Smith; Timothy M Ritty; James H Adair; Mark Kester
Journal:  ACS Nano       Date:  2013-02-14       Impact factor: 15.881

8.  Tricalcium phosphate and tricalcium phosphate/polycaprolactone particulate composite for controlled release of protein.

Authors:  Sahar Vahabzadeh; Joe Edgington; Susmita Bose
Journal:  Mater Sci Eng C Mater Biol Appl       Date:  2013-04-10       Impact factor: 7.328

9.  Phase composition control of calcium phosphate nanoparticles for tunable drug delivery kinetics and treatment of osteomyelitis. I. Preparation and drug release.

Authors:  Vuk Uskoković; Tejal A Desai
Journal:  J Biomed Mater Res A       Date:  2012-10-31       Impact factor: 4.396

10.  Effective encapsulation and biological activity of phosphorylated chemotherapeutics in calcium phosphosilicate nanoparticles for the treatment of pancreatic cancer.

Authors:  Welley S Loc; Samuel S Linton; Zachary R Wilczynski; Gail L Matters; Christopher O McGovern; Thomas Abraham; Todd Fox; Christopher M Gigliotti; Xiaomeng Tang; Amra Tabakovic; Jo Ann Martin; Gary A Clawson; Jill P Smith; Peter J Butler; Mark Kester; James H Adair
Journal:  Nanomedicine       Date:  2017-07-01       Impact factor: 5.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.